IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 137 filers reported holding IMMUNOGEN INC in Q1 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
| BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
| SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
| Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
| Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
| Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
| PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
| FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
| Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |